Environmental risk assessment of medicines
There are nearly 2 000 active pharmaceutical ingredients (APIs) in use, but little is known about the risks they pose to the environment. As a result, there is an urgent need for science-based methods that identify environmental threats earlier in the drug development process. The EU-funded PREMIER project proposes an information and assessment system based on minimum testing that describes the environmental risk of APIs, including relevant human metabolites and environmental transformation products. The system will deliver tailored assessment, identify potential environmental damage and make existing environmental data more accessible for all stakeholders. The project will combine world-leading research on the environmental threats represented by APIs with the principles of co-design and smart knowledge-based IT.
Call for proposal
See other projects for this call
Funding SchemeIMI2-RIA - Research and Innovation action
YO1 8QG York